Omthera submits Epanova NDA

Omthera Pharmaceuticals Inc. (NASDAQ:OMTH) submitted an NDA to FDA for Epanova to treat severe hypertriglyceridemia, defined as triglyceride levels greater than or equal to 500 mg/dL. Epanova is an ul...